221/314US=23-B / Câncer
Schumacher LY, Baril NB, Wren SM. Esophageal cancer: initial staging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 83-95. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE ESOFAGO; ESTADIAMENTO INICIAL; MODALIDADES DE ESTADIAMENTO PRE-OPERATORIOS; TUMOR PRIMARIO; ESTAGIO T; LINFONODO REGIONAL; ESTAGIO N; DOENCA METASTATICA; ESTAGIO M; TORACOSCOPIA; LAPAROSCOPIA


222/314US=23-B / Câncer
Ficsor L, Molnar B. Automated disease classification of colon and gastric histological samples based on digital microscopy and advanced image analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 99-111. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; DOENCA DE COLON; HISTOLOGIA; MICROSCOPIA DIGITAL; ANALISE DE IMAGENS


223/314US=23-B / Câncer
Yokozaki H, Hasuo T, Satake S, Omori Y, Maeda N, Nakamura K, Semba S. Early gastric cancer: prediction of metachronous recurrence using endoscopic submucosal dissection (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 113-20. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO PRECOCE; DISSECCAO ENDOSCOPICA DA SUBMUCOSA


224/314US=23-B / Câncer
Devaraj H, Kumar AA, Devaraj N. Helicbacter pylori-infected neoplastic gactric epithelium: expression of MUC2 as a biomarker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 121-36. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; HELICBACTER PYLORI; EXPRESSAO DE MUC2; BIOMARCADOR; MECANISMO MOLECULAR; MUCINAS; DIAGNOSTICO MOLECULAR


225/314US=23-B / Câncer
Shiotani A, Haruma K, Graham DY. Gastric cancer: role of intestinal metaplasia by histochemical detection using biopsy specimens. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 137-51. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; METAPLASIA INTESTINAL; HISTOQUIMICA; BIOPSIA; GASTRITE ATROFICA; EXPRESSAO CDX2


226/314US=23-B / Câncer
Peng Z, Xie K. Gastric cancer: antitumor activity of RUNX3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 153-62. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; ATIVIDADE ANTITUMORAL; RUNX3


227/314US=23-B / Câncer
Kitano S, Yasuda K, Shiraishi N. Early gastric cancer: laparoscopic gastrectomy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 163-70. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; CANCER GASTRICO PRECOCE; GASTRECTOMIA LAPAROSCOPICA


228/314US=23-B / Câncer
Kakeji Y, Oki E, Sadanaga N, Morita M, Maehara Y. Gastric cancer: overexpression of hypoxia-inducible factor 1 as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 171-80. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTRICO; FATOR 1 INDUZIVEL POR HIPOXIA; PROGNOSTICO


229/314US=23-B / Câncer
Tomita Y, Uyama H, Nakamura H. Pancreatic cancer: hepatoma-derived growth factor as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 183-9. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; HEPATOMA; FATOR DE CRESCIMENTO DERIVADO; FATOR PROGNOSTICO; IMUNOHISTOQUIMICA


230/314US=23-B / Câncer
Higashi T. Pancreatic cancer: 18F-Fluorodeoxyglucose positron emission tomography as a prognostic parameter. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 191-203. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; 18F-FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS; PARAMETRO DE PROGNOSTICO


231/314US=23-B / Câncer
Ohike N, Kawahara M, Takahashi M, Sugihara A, Gokan T, Morohoshi T. Imaging and pathologic findings of peculiar histologic variants of pancreatic endocrine tumors. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 205-10. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; TUMORES ENDOCRINOS PANCREATICOS; IMAGEM; ACHADOS PATOLOGICOS; HISTOLOGIA


232/314US=23-B / Câncer
Bowen KA, Riall TS. Periampullary adenocarcinoma: diagnosis and survival after pancreaticoduodenectomy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 211-26. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; ADENOCARCINOMA PERIAMPOLAR; PANCREATODUODENECTOMIA; FATORES DE RISCO; DIAGNOSTICO; ESTADIAMENTO; TERAPIA ADJUVANTE; TERAPIA NEOADJUVANTE


233/314US=23-B / Câncer
Kurt E, Kurt M, Evrensel T, Ozkan L, Manavoglu O. Unresectable locally advanced pancreatic cancer: concurrent chemotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 227-36. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; CARCINOMA DO PANCREAS LOCALMENTE AVANCADO; QUIMIOTERAPIA CONCOMITANTE


234/314US=23-C / Câncer
Hayat MA. Introduction: colorectal cancer. In: ___. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 3-9. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; DIAGNOSTICO; TRATAMENTO


235/314US=23-C / Câncer
Shinji S, Naito Z, Ishiwata T, Matsuda Y, Seya T, Tajiri T. Poorly differentiated colorectal adenocarcinoma (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 13-23. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; ADENOCARCINOMA COLORRETAL POUCO DIFERENCIADO; HISTOPATOLOGIA; IMUNOHISTOQUIMICA; HIBRIDIZACAO IN SITU


236/314US=23-C / Câncer
Alnabulsi A, Carpenter B, Telfer C, Murray GI. Colorectal cancer: immunohistochemical diagnosis with heterogeneous nuclear ribonucleoprotein K. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 25-42. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; RIBONUCLEOPROTEINA K; BIOMARCADORES


237/314US=23-C / Câncer
Obradovic V, Artiko V. Metastases and recurrence of colorectal cancer: diagnostic role of immunoscintigraphy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 43-63. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; METASTASES; RECORRENCIA; DIAGNOSTICO; IMUNOCINTIGRAFIA


238/314US=23-C / Câncer
Flamini E, Calistri D, Mercatali L, Rengucci C, Amadori D. Colorectal cancer diagnosis using DNA levels in blood and stool. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 65-81. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; DIAGNOSTICO; NIVEIS DE DNA; EXAME DE FEZES; EXAME DE URINA


239/314US=23-C / Câncer
Bandres E, Bitarte N, Ramirez N, Zarate R, Garcia-Foncillas J. Colorectal carcinoma: identification of microRNAs using real-time polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 83-102. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; DIAGNOSTICO; IDENTIFICACAO DE MICRORNAS; TEMPO REAL; REACAO EM CADEIA DA POLIMERASE; BIOGENESE DE MICRORNA; BIOINFORMATICA


240/314US=23-C / Câncer
Barone C, Landriscina M, Cassano A. Colorectal cancer: optimization of the combination of 5-Fluorouracil and Irinotecan. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 105-17. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; TRATAMENTO; 5-FLUOROURACIL; IRINOTECAN; FARMACOLOGIA CLINICA; OTIMIZACAO CLINICA; FARMACOGENOMICA


Primeira | Anterior | Próxima | Última